Tempus AI (NASDAQ:TEM) Shares Gap Up – Time to Buy?

Tempus AI, Inc. (NASDAQ:TEM) gapped up before the market opened on Monday . The stock had previously closed at $51.35, but opened at $54.94. Tempus AI shares last traded at $56.83, with a volume of 2,711,940 shares changing hands.

Analyst Ratings Changes

A number of equities research analysts have weighed in on TEM shares. Guggenheim reaffirmed a “buy” rating on shares of Tempus AI in a report on Tuesday, February 25th. Piper Sandler reduced their target price on Tempus AI from $70.00 to $55.00 and set a “neutral” rating on the stock in a report on Tuesday, March 4th. Morgan Stanley boosted their target price on Tempus AI from $50.00 to $60.00 and gave the stock an “overweight” rating in a report on Thursday, March 6th. Bank of America boosted their target price on Tempus AI from $54.00 to $60.00 and gave the stock a “neutral” rating in a report on Monday, March 3rd. Finally, Loop Capital reduced their target price on Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a report on Tuesday, January 14th. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $61.18.

Tempus AI Stock Performance

The firm has a fifty day simple moving average of $56.35 and a 200-day simple moving average of $51.38. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17.

Insider Buying and Selling at Tempus AI

In other Tempus AI news, COO Ryan Fukushima sold 20,000 shares of the company’s stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $39.61, for a total transaction of $792,200.00. Following the completion of the sale, the chief operating officer now owns 982,442 shares in the company, valued at approximately $38,914,527.62. The trade was a 2.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, major shareholder Bradley A. Keywell sold 170,720 shares of the company’s stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $35.45, for a total transaction of $6,052,024.00. Following the sale, the insider now owns 15,993,729 shares of the company’s stock, valued at $566,977,693.05. The trade was a 1.06 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 5,598,969 shares of company stock worth $317,194,162.

Institutional Trading of Tempus AI

A number of large investors have recently made changes to their positions in the company. GF Fund Management CO. LTD. bought a new stake in shares of Tempus AI in the 4th quarter valued at $108,000. Voloridge Investment Management LLC bought a new stake in shares of Tempus AI in the 4th quarter valued at $11,826,000. Two Sigma Advisers LP bought a new stake in shares of Tempus AI in the 4th quarter valued at $625,000. ProShare Advisors LLC bought a new stake in shares of Tempus AI in the 4th quarter valued at $244,000. Finally, Lazard Asset Management LLC bought a new stake in shares of Tempus AI in the 4th quarter valued at $1,034,000. Institutional investors own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.